Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is rarely fatal in
children and young people (CYP,< 18 years old), but quantifying the risk of death is …

Background Understanding the effects of the COVID-19 pandemic on cause-specific
mortality should be a priority, as this metric allows for a detailed analysis of the true burden …

Infants remain at high risk for severe coronavirus disease 2019 (COVID-19). Human milk
contains high levels of protective SARS CoV-2 specific antibodies post-infection and primary …

Importance During the first year of the COVID-19 pandemic, child mortality in England was
the lowest on record, but if this trend will continue, or if unrecognized morbidity during the …

Importance Although the immediate impact of neonatal illness is well recognized, its wider
and longer term outcomes on childhood mortality and the role of specific illnesses across …

Background Coronavirus Disease 2019 (COVID-19) deaths are rare in children and young
people (CYP). The high rates of asymptomatic and mild infections complicate assessment of …

Background The coronavirus disease-19 (COVID-19) pandemic had a relatively minimal
direct impact on critical illness in children compared to adults. However, children and …

Importance England has one of the highest infant mortality rates in Europe. Much of the
variation in infant mortality rates between races and ethnicities may be due to …

The incidence of COVID in pediatrics was underestimated during the first months of the
pandemic due to the oligo-symptomatic nature of the infection in many children and the …

Debate persists around the risk–benefit balance of vaccinating adolescents and children
against COVID-19. Central to this debate is quantifying the contribution of adolescents and …